Jiangsu Hengrui Pharmaceuticals (SHA:600276) repurchased around 1.6 million A-shares for a total of 73.9 million yuan as of Oct. 31 under its share buyback program.
The repurchased shares account for 0.025% of the company's total share capital, according to a Tuesday filing with the Shanghai bourse. The purchase prices ranged from 43.10 yuan to 46.33 yuan per share.
In October alone, the company bought back about 1.1 million shares for 48.0 million, at prices ranging from 44.80 yuan to 46.33 yuan per share.
Hengrui launched the buyback plan in August, with a total repurchase target of 1 billion yuan to 2 billion yuan. It intends to use the repurchased shares for an employee stock ownership plan.
Comments